NR Chloride vs Hydrogen Malate: Forms, NRH and the Evidence

NR chloride and NR hydrogen malate are salts containing the nicotinamide riboside cation with different counterions. The distinction affects chemical identity and label arithmetic. It does not by itself establish that one finished product delivers better clinical outcomes.

Reduced NR, usually called NRH, is a different chemical exposure again. It should not be confused with hydrogen malate simply because both names contain “hydrogen.” This guide separates those forms, their evidence and the numbers printed on current labels.

What does the chloride do?

A salt pairs charged components. NR chloride combines NR with chloride; NR hydrogen malate uses a hydrogen-malate counterion. The counterion contributes to the total mass and can affect properties such as crystallization, handling or stability.

The presence of chloride does not mean the product is chlorine bleach, just as a chemical name containing “nicotinamide” does not make it nicotine. Evaluate the actual compound and exposure rather than reacting to a familiar word taken out of context.

The 2021 crystalline-salts paper describes synthesis, structures and stability-related work for hydrogen malate and hydrogen tartrate forms. It is useful chemistry, but it is not a human trial demonstrating superior cognition, energy or longevity. ^[1]

The main forms at a glance

A salt name, a delivery system and a redox-state change describe different dimensions. A product can have both a salt and a delivery descriptor; neither removes the need to state the amount and full formula.

Which form has the human NR evidence?

Many important oral NR studies used NR chloride, often a specified branded ingredient. The 140-person dose-response trial tested 100, 300 and 1,000 mg/day of NR chloride for eight weeks and found dose-dependent whole-blood NAD+ increases. ^[2]

That evidence is relevant to the tested ingredient and regimen. It does not prove that every brand containing the same named salt has identical potency, stability or clinical performance. Quality documentation and formulation still matter.

It also does not automatically establish the same exposure from an equal milligram amount of hydrogen malate. A clinical equivalence argument needs a clear dose basis and, where relevant, direct comparative data. Chemical plausibility can support investigation without replacing that comparison.

What does the hydrogen-malate safety paper establish?

The 2022 report assessed NR hydrogen malate in nonclinical test systems, including repeat-dose rat studies and genotoxicity-related assays. It did not find genotoxicity under its tested conditions and reported sex-specific rat no-observed-adverse-effect levels. ^[3]

Those results contribute to a safety dossier. They are not a human efficacy trial, an unrestricted human intake limit or proof of superior absorption. A rat amount expressed in mg/kg/day should not be copied onto a consumer label or converted into a self-directed regimen.

The distinction is particularly important when a commercial page places “clinically researched NR” beside a paper that actually concerns animal safety of a different salt. Both may be relevant sources, while answering different questions.

Salt mass is not the same as NR mass

A larger salt mass may include more counterion rather than more NR. Hydration state, purity and the manufacturer's labeling basis can complicate calculations further. The correct approach is to obtain the product specification or explicit NR-equivalent declaration rather than assuming that every front-label milligram is directly comparable.

Current Thorne labels illustrate the issue. NiaCel 400 lists 415 mg of NR hydrogen malate per one-capsule serving. ResveraCel lists the same declared salt amount per two-capsule serving, alongside other active ingredients. Those statements do not establish 415 mg of NR alone or superiority over a 300 mg NR chloride product.

The number “400” in a product name is also not a substitute for reading the current ingredient panel. Product names can persist while formulas, serving sizes or salt forms change.

How to compare two labels correctly

First record the exact SKU, serving size, salt name and declared amount. Then determine whether the amount represents the salt, NR itself or a complex. Preserve the wording if the basis cannot be verified.

For practical intake examples, see the dosage guide. For current versions, see the NiaCel 400 review and ResveraCel review.

Does a different salt absorb better?

Potential differences in solubility or stability justify measurement, but neither is automatically a clinical advantage. The relevant study would need the exact preparations, comparable NR exposure, an appropriate route and a meaningful endpoint.

A chemical synthesis paper can demonstrate a feasible manufacturing route or a crystalline structure. It cannot by itself show that people feel more energetic, think better or age more slowly after taking the corresponding commercial capsule. The authors of the salts paper disclosed commercial relationships with a supplier of NR derivatives, which should be considered alongside the methods rather than treated as either proof or disproof of the chemistry. ^[1]

Likewise, a product's quality certification does not establish pharmacokinetic or clinical superiority. These are different evidence categories and should be evaluated separately.

Hydrogen malate is not NRH

NRH is reduced nicotinamide riboside. Hydrogen malate names the counterion in a salt of ordinary oxidized NR. The two descriptions are not alternate spellings and should not share a dose recommendation by default.

Preclinical work on reduced precursors can identify distinct pathways or strong biochemical effects. That does not establish routine consumer efficacy or long-term safety. A larger increase in a cell experiment is not a human clinical superiority result.

The 2019 NRH paper describes a reduced precursor and its biological handling in experimental systems. Its findings should remain separate from conventional NR chloride human studies. ^[4]

Do not buy a product assuming that the shortest name or most dramatic NAD+ multiplier identifies the best-established option. Ask whether the actual molecule on the label has the human evidence being cited.

Stability, powder and storage

Crystalline form, humidity, temperature, pH and packaging can influence stability. The salts paper examined laboratory properties under specified conditions; it does not define the shelf life of every finished product in every home environment. ^[1]

Follow the product's storage directions and keep it in suitable packaging. A powder dissolved for immediate use and a premixed solution stored for days are different conditions. A claim that one salt is stable does not establish that an unrelated mixture retains potency after prolonged heat or moisture exposure.

If documentation gives only a raw-material assay, ask what stability and finished-product information applies to the bottle being purchased. Appearance and taste are not validated potency tests.

What this means for product selection

A clearly labeled conventional chloride product has the advantage of easier connection to several published human protocols. A clearly labeled hydrogen-malate formula may be a reasonable product choice for other practical reasons, but it should not borrow claims that have not been demonstrated for its formulation.

The best-NR comparison preserves these distinctions rather than declaring the biggest salt number the winner. The liposomal guide addresses delivery claims separately.

Finally, the NR Data Center separates human trials from chemical and nonclinical work. The most useful form comparison is transparent about what is known, what is measured on the label and where a direct equivalence claim remains unsupported.